Flavonoids: Potential therapeutic agents for cardiovascular disease

被引:11
|
作者
Liu, Yingxue [1 ]
Luo, Jing [1 ]
Peng, Lin [2 ]
Zhang, Qi [1 ]
Rong, Xi [1 ]
Luo, Yuhao [3 ]
Li, Jiafu [1 ,4 ]
机构
[1] Southwest Med Univ, Dept Cardiol, Affiliated Hosp, Luzhou, Peoples R China
[2] Southwest Med Univ, Dept Bone & Joint Surg, Affiliated Hosp, Luzhou, Peoples R China
[3] Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou, Peoples R China
[4] Southwest Med Univ, Collaborat Innovat Ctr Prevent & Treatment Cardiov, Luzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Flavonoid; Cardiovascular disease; Bioavailability; Inflammation; Antioxidant; CORONARY-HEART-DISEASE; PULMONARY-HYPERTENSION; MYOCARDIAL FIBROSIS; DIETARY FLAVONOIDS; PHENOLIC-COMPOUNDS; GLOBAL BURDEN; ATHEROSCLEROSIS; INFLAMMATION; PREVENTION; FAILURE;
D O I
10.1016/j.heliyon.2024.e32563
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Flavonoids are found in the roots, stems, leaves, and fruits of many plant taxa. They are related to plant growth and development, pigment formation, and protection against environmental stress. Flavonoids function as antioxidants and exert anti-inflammatory effects in the cardiovascular system by modulating classical inflammatory response pathways, such as the TLR4-NF-& kgreen;B, PI3KAKT, and Nrf2/HO-1 signalling pathways. There is increasing evidence for the therapeutic effects of flavonoids on hypertension, atherosclerosis, and other diseases. The potential clinical value of flavonoids for diseases of the cardiovascular system has been widely explored. For example, studies have evaluated the roles of flavonoids in the regulation of blood pressure via endotheliumdependent and non-endothelium-dependent pathways and in the regulation of myocardial systolic and diastolic functions by influencing calcium homeostasis and smooth muscle-related protein expression. Flavonoids also have hypoglycaemic, hypolipidemic, anti-platelet, autophagy, and antibacterial effects. In this paper, the role and mechanism of flavonoids in cardiovascular diseases were reviewed in order to provide reference for the clinical application of flavonoids in the future.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Potential therapeutic effects of some flavonoids on coronavirus disease 2019
    Khazdair, Mohammad Reza
    PHYSIOLOGY AND PHARMACOLOGY, 2021, 25 (02): : 99 - 101
  • [22] FLAVONOIDS AS PROMISING THERAPEUTIC AND DIETARY AGENTS
    Lungu, I. I.
    Huzum, B.
    Humulescu, Ioana Alexandra
    Cioanca, Oana
    Morariu, Daniela
    Serban, Ionela-Lacramioara
    Hancianu, Monica
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2020, 124 (01): : 151 - 156
  • [23] FLAVONOIDS AS POTENTIAL ANTIALLERGIC AGENTS
    SARAF, AS
    OGANESYAN, ET
    KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1991, 25 (02): : 4 - 8
  • [24] Adrenomedullins and urocortins: Therapeutic potential in cardiovascular disease
    Charles, Christopher J.
    ENDOCRINE JOURNAL, 2010, 57 : S212 - S212
  • [25] Mitochondrial remodeling in cardiovascular disease: Therapeutic potential
    Balachander, Kannan
    Priyadharsini, Jayaseelan Vijayashree
    Paramasivam, Arumugam
    HYPERTENSION RESEARCH, 2023, 46 (02) : 542 - 543
  • [26] Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease
    Calway, Tyler
    Kim, Gene H.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2015, 20 (02) : 131 - 143
  • [27] Osteopontin in Cardiovascular Disease A Potential Therapeutic Target
    Waller, Alfonso H.
    Sanchez-Ross, Monica
    Kaluski, Edo
    Klapholz, Marc
    CARDIOLOGY IN REVIEW, 2010, 18 (03) : 125 - 131
  • [28] Mitochondrial remodeling in cardiovascular disease: Therapeutic potential
    Kannan Balachander
    Jayaseelan Vijayashree Priyadharsini
    Arumugam Paramasivam
    Hypertension Research, 2023, 46 : 542 - 543
  • [29] Astaxanthin: A Potential Therapeutic Agent in Cardiovascular Disease
    Fassett, Robert G.
    Coombes, Jeff S.
    MARINE DRUGS, 2011, 9 (03) : 447 - 465
  • [30] Therapeutic Potential and Mechanisms of Berberine in Cardiovascular Disease
    Zhang M.
    Feng L.
    Li J.
    Chen L.
    Current Pharmacology Reports, 2016, 2 (6) : 281 - 292